Dublin, Dec. 05, 2017 -- The "Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 - 2017) and Future Forecast (2018 - 2025)" report has been added to Research and Markets' offering.
The report Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 - 2017) and Future Forecast (2018 - 2025) offers the most up-to-date industry data on the actual market situation and future outlook for insulin pen across the ten major markets (10MM).
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. A comprehensive analysis has been done on market share of insulin pen segment.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
- Novo Nordisk
- Eli Lilly
- Sanofi
- Owen Mumford
- Ypsomed
- Biocon Ltd.
Key Findings:
- Germany accounted for 15% of the insulin delivery pen market in 2017
- China dominates the reusable insulin delivery pen market
- Reusable insulin delivery pen has the highest volume share in the overall insulin delivery pen market
- Disposable insulin delivery pen is expected to register a faster value growth during 2018-2025
- Japan is the third largest insulin delivery pen market
- Flexpen, Solostar and KwikPen are the leading brand in the insulin delivery pen sector
The Latest Industry Data Included in this Report:
- Diabetes Population in 10 major market(10MM) 2011-2025
- Insulin Users Insights in 10 major market(10MM) 2011-2025
- Overall Insulin Delivery Pen Users, 2011-2025
- Overall Insulin Delivery Pen Market Size, 2011-2025
- Insulin Delivery Pen Market Size by Product Segments, 2011-2025
- Growth Rates of the Overall Market and Different Product Segments, 2011-2025
- Shares of Different Product Segments of the Overall Market, 2011- 2025
- Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
- A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Recent Development
The Report Facilitates Answer the Subsequent Questions:
- What is the size of the insulin delivery pen market in 10 major market(10MM)?
- How much reusable and disposable pen users in 10 major market(10MM)?
- How is the insulin delivery pen market divided into two different types of segments?
- How are the overall market and segments types growing?
- How is the market predicted to develop in the future?
- Who are the market players?
Key Topics Covered:
1. Executive Summary
2. Insulin Delivery Pen Market in Top Ten Countries - Market Overview
2.1 10 Countries - Overall Insulin Pen Users & Forecast
2.2 10 Countries - Overall Insulin Pen Market & Forecast
2.3 10 Countries - Overall Insulin Pen Users Share & Forecast
2.4 10 Countries - Overall Insulin Pen Market Share & Forecast
3. Insulin Delivery Pen Market Drivers and Barriers
3.1 Market Drivers
3.2 Market Barriers
4. Insulin Delivery Pen Market in Top Ten Countries - Geographical Landscape
4.1 United States
4.2 Germany
4.3 France
4.4 Italy
4.5 Spain
4.6 United Kingdom
4.7 Japan
4.8 China
4.9 India
4.10 Brazil
5. Key Companies Analysis
- Biocon Ltd.
- Eli Lilly
- Novo Nordisk
- Owen Mumford
- Sanofi
- Ypsomed
For more information about this report visit https://www.researchandmarkets.com/research/r2q54x/global_insulin
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diabetes Devices


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



